CLLS Stock Analysis: Buy, Sell, or Hold?

CLLS - Cellectis S.A. American Depositary Shares

Biological Products, (No Diagnostic Substances)
$3.41
-0.07 (-1.87%) ▼
5d: +11.64%
30d: +22.92%
90d: -3.27%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 03, 2026 0d

Get Alerted When CLLS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 MIXED SIGNALS: CLLS shows conflicting indicators. Wait for confirmation before entering.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: CLLS is currently trading at $3.40, which is considered extended relative to its 30-day fair value range of $2.68 to $3.10.

Technical Outlook: Technically, CLLS is in a strong downtrend. The price is approaching resistance at $3.48. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: CLLS scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.60 (+123.2%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $2.68 - $3.10
Company Quality Score 35/100 (SELL)
Volume Confirmation HIGH
Confidence Score 21.1%

All Signals

  • BEARISH: Price extended above range (+9.8% above its trading range)
  • BEARISH: Weak technical setup (15/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 123.2% below Wall St target ($7.60)
  • WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $2.68 - $3.10
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $2.64
Resistance Level $3.48
Current Trend Strong Downtrend
Technical data as of Aug 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) -4.14
Wall Street Target $7.60 (+123.2%)
Revenue Growth (YoY) -62.1%
Profit Margin -102.3%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 23, 2026 6:30 PM ET
Data refreshes hourly during market hours. Next update: 7:30 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for CLLS.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NTLA
Intellia Therapeutics Inc
STRONG BUY
29 analysts
$24 33 SELL
ARGX
argenx NV ADR
STRONG BUY
22 analysts
$1173 43 HOLD
REGN
Regeneron Pharmaceutical…
STRONG BUY
25 analysts
$840 34 SELL
JAZZ
Jazz Pharmaceuticals PLC
STRONG BUY
18 analysts
$281 55 HOLD
MLTX
MoonLake Immunotherapeut…
STRONG BUY
16 analysts
$29 49 HOLD

More Analysis for CLLS

CLLS Technical Chart CLLS Price Prediction CLLS Earnings Date CLLS Investment Advisor CLLS Fair Price Analyzer CLLS Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals